Cardiovascular

Atorvastatin Reloading Before PCI Cuts Mortality After Myocardial Infarction Even In Patients Already On Statins

April 2, 2009
Germano Di Sciascio
Germano Di Sciascio

Germano Di Sciascio, Campus Bio-Medico University, Rome
ACC 58th Annual Scientific Session, 28-31 March, 2009, Orlando—Peter Goodwin hears from Germano Di Sciascio of the Campus Bio-Medico University of Rome latest data on mortality from the Atorvastatin for Reduction of Myocardial Infarction during Angioplasty—ARMYDA—study—which looked at preloading patients with Atorvastatin before PCI.

Download this interview

Add podcast to iTunes

Similar Interviews

  • Audio Journal of Cardiovascular Medicine: Reduced Mortality and Repeat MI with Enoxaparin for Patients with ST Elevation Myocardial Infarction

    • HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: European Heart Journal Advanced On-Line Publication April 24th, 2007 Enoxaparin could be the new

  • Aggressive Statins: the IDEAL Treatment

    • Terje Pedersen More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly

  • Do Blood Transfusions Increase Mortality Risk in Patients with Acute Myocardial Infarction?

    • Vivek Rajagopal, The Cleveland Clinic Foundation, OH American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 973-234 Patients

    Post a comment